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Changes in cell morphology are essential for generating the complex tissues that make up all 
organisms. Regulation of the cell’s morphology is dynamic and is achieved through the 
coordinated activity of numerous signaling pathways and proteins that converge on the 
cytoskeleton at many levels. In epithelial cells, the Shroom family of proteins drives anisotropic 
changes to morphology such as apical constriction and convergent extension in the formation of 
such structures as the neural tube, vasculature, gut, and eye. Shroom proteins are a class of actin-
binding proteins that recruit Rho-associated coiled-coil Kinase (or Rock), to the cytoskeleton to 
induce contraction of the actin network and effect change. Recent work in this field has focused 
on understanding the direct interaction of Shroom and Rock, but little work has been done to 
understand how Shroom proteins directly interact with actin. The actin-binding ability of these 
proteins has been localized to Shroom Domain 1, a domain unique to Shroom proteins. My work 
has centered on better understanding the interaction between the SD1 and actin. 
 I have identified small, conserved regions of both Shroom2 and Shroom3 that are capable 
of binding and bundling actin with similar affinity. With the use of Transmission Electron 
Microscopy, I observed that both proteins organize actin filaments into similar tightly packed 
parallel or anti-parallel bundles. While Shroom proteins localize to different populations of actin 
within the cell, it appears that the ability to bind and bundle actin has been conserved, and that 
other region of the proteins must drive their unique localization patterns. 
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1.0  INTRODUCTION 
1.1 CELL MORPHOLOGY AND THE NEURAL TUBE 
In order for complex structures and organs to form in a developing embryo, drastic changes must 
occur to cell morphology. These include changes to cell shape, size, location, and fate and all are 
controlled or modified through complex interactions of regulatory pathways and the 
cytoskeleton. Many of these pathways, at their most basic level, are involved in the 
rearrangement of the actomyosin network in epithelial cells. One example of a pathway involved 
in these rearrangements of the actomyosin network is the Planar Cell Polarity (PCP) pathway [1, 
2]. This pathway helps to regulate the anisotropic changes to cell morphology that drive the 
formation of such structures as the neural tube [3-5]. When we think of anisotropic changes to 
cell morphology, we can think of two particular examples involved in the formation of the neural 
tube: apical constriction and convergent extension (Fig. 1.1). Apical constriction is the process 
by which cells specifically constrict on their apical surface, while their basal side remains 
relatively unchanged [6]. This transformation from a columnar to a wedge shape allows flat 
sheets of cells to transform into curved tissues. Apical constriction is apparent in the 
development of the neural tube, but also in other structures such as the eye [7, 8].  
Convergent extension, by comparison, is the process by which cells differentially 
contract mediolateral cell-cell borders and not anterior-posterior borders, leading to an 
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anisotropic change in cell morphology (Fig. 1.1 B & D) [2, 9]. By contracting in the mediolateral 
direction, cells can intercalate between each other. The cells converge as a rosette, and then 
extend in anterior-posterior direction. This extends a wide, short tissue into a long, narrow tissue 
without needing to increase the total number of cells. Convergent extension allows the 
developing embryo to extend its body axis [4]. The PCP pathway regulates the location of other 
pathways and helps to direct these localized anisotropic changes to cell morphology needed for 
tissue bending [2]. 
 
Figure 1.1: Changes to cell shape are critical to development.  
Regulation of the actomyosin network of cells is at the center of A) apical constriction and B) convergent extension. 
These anisotropic changes to cell shape can be seen in the C) bending of tissue (apical constriction) and D) tissue 
extension (convergent extension) through rosette formation. 
Convergent Extension 
Anterior 
Posterior Mediolateral 
Apical 
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Apical Constriction 
M
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1.2  ACTIN 
Actin is found in all metazoan cells. Actin and the other components of the cytoskeleton 
contribute to many aspects of dynamic cell behavior, such as cell shape change, migration, and 
transport of materials in the cell. Actin often works in complex with actin-binding proteins 
(ABPs), to regulate cellular responses to extracellular stimuli [10-18]. Actin is found in two 
states, monomeric globular (G) actin and filamentous (F) actin. G-actin is polymerized into F-
actin in an ATP-assisted manner. G-actin can be added to either end of a filament, though it is 
more common to be added to the growing end known as the barbed end (or + end). At the other 
end, known as the pointed end (or – end) of the F-actin filament, G-actin monomers will 
spontaneously de-polymerize from the filament [15-17, 19, 20]. This cycling of G-actin to F-
actin to G-actin creates a constant flux in the population of actin in the cell.  
F-actin can be further organized into different arrays such as branched networks, bundled 
cables, and gel-like mesh [10, 13, 21-27]. These different architectures allow actin to play many 
different roles in a cell. For example, bundled parallel actin filaments, in the presence of myosin, 
can be contracted against each other to generate force that is critical to changing a cell’s shape 
[18, 28, 29]. Branched networks of actin are critical to giving a cell rigidity, facilitating 
migration, and dictating the overall shape of the cell [19].  
1.2.1 Actin Binding Proteins 
While actin can do many things on its own, it also works in conjunction with numerous ABPs. 
Fig. 1.2 shows examples of the four classes of ABPs: A) polymerization regulators, B and C) 
architecture modifiers, D) translocation and force generation, and E) anchoring proteins. ABPs 
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are a complex group of proteins that employ a diverse range of binding sites and motifs to 
associate with actin. More than 18 different actin-binding motifs have been identified [22]. 
While some motifs can be found across several actin-binding proteins, such as the C2 domain 
found in Protein Kinase C-delta and Fragmin60, others are more specialized to specific ABPs 
such as the actin-binding motifs of Myosin and Profilin [17, 22, 23, 30, 31]. Actin itself contains 
many different binding sites that ABPs use, adding to the diversity of interactions.  
 
Figure 1.2: Four Classes Of Actin Binding Proteins.  
A) Polymerization; Nucleation promoters (Profilin) and capping proteins (CapZ), B) F-actin architecture; bundling 
proteins (a-Actinin and Fimbrin), C) F-actin-architecture; branching networks (Arp2/3 complex, also a Nucleation 
Promoting Factor, NPF), D) Translocation; myosin, E) Anchoring actin; proteins that link actin to the cell membrane 
(Catinins linked to Cadherin). There is evidence to suggest that Shroom proteins exhibit activities consistent with 
more than one category of actin-binding protein.  
A B 
C D E 
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1.2.1.1 Polymerization 
Profilin and the Arp2/3 complex are two examples of ABPs that facilitate the nucleation (Arp2/3, 
Fig 1.2C) and growth (Profilin, Fig 1.2A) of F-actin [22, 32]. Profilin regulates the elongation of 
F-actin in several ways. Profilin binds G-actin and sequesters it from the available pool of G-
actin available for spontaneous filament assembly [22, 27]. It helps catalyze the transition from 
ADP-actin to ATP-actin. ATP-actin is more readily polymerized than ADP-actin. Profilin also 
interacts with Ena/VASP proteins that promote the elongation of F-actin [22].  
The Arp2/3 complex works by mimicking several G-actin monomers in the orientation of 
those in an F-actin filament. The Arp2/3 complex can bind the side of an F-actin filament and 
create a branch point in the filament. G-actin will be added now to both + ends, that of the 
original filament as well as the new branch. This creates a branched/mesh network, important in 
creating force and strength at the edge of a cell. The WAVE and WASP family of proteins work 
in conjunction with the Arp2/3 complex to help promote the polymerization of actin [11, 22, 33-
38]. 
At the pointed end of the F-actin filament, capping proteins, such as CapZ (Fig 1.2A), 
bind to and stabilize the filament from depolymerizing. Stabilizing the F-actin makes the 
filaments more resistant to de-polymerization and degradation. Cofilin on the other hand actively 
de-polymerizes F-actin back into G-actin. Finally, there are proteins such as Gelsolin that cleave 
F-actin into small fragments. This group of actin-binding proteins are especially diverse and 
several of them play additional roles in regulating actin [22]. 
1.2.1.2 Architecture 
The next group of ABPs are the architecture-modifying proteins (Fig 1.2 B and C). F-actin can 
adopt several different geometries in a cell, including bundles, branched filaments, and gel-like 
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networks. As mentioned above, the Arp2/3 complex helps to branch F-actin by binding the side 
of an F-actin filament (Fig 1.2C). The filament can now continue to polymerize in two directions 
[34, 36, 37]. Another ABP, Filamin, binds F-actin and creates networks of filaments at 90° 
angles to each other, creating a mesh. This mesh of actin commonly helps to create strength and 
rigidity at the cellular periphery [18, 27]. 
Bundles are formed when multiple F-actin filaments are brought together in either a 
parallel or anti-parallel orientation (Fig 1.2B). ABPs that crosslink actin filaments into bundles 
must have multiple actin-binding motifs [10, 13, 21, 23, 25, 26, 32, 39, 40]. Monomoers 
containing a single actin-binding motif must mulitmerize in order to bundle actin. α-Actinin and 
Villin are two examples of actin bundling proteins that dimerize. α-Actinin has a single actin-
binding motif, however it dimerizes in an anti-parallel formation. This positions the actin-
binding motifs approximately 30 nm apart, facilitating a loose actin bundle. This gap is sufficient 
for Myosin to  fit between the F-actin filaments [26].  
Villin is an interesting example of an ABP with unique properties and regulation. Unlike 
α-Actinin, Villin has two functionally different actin-binding motifs, one in the head domain and 
one in the core. The actin-binding motif of the head is solely for binding actin, while the one in 
the core of the protein is required for Ca2+-dependent cleavage of F-actin. Villin can dimerize in 
a manner that blocks the core binding site. This allows the actin-binding motifs of the dimer to 
crosslink actin filaments. Villin induces a tighter actin bundle than that of α-Actinin, as it 
dimerizes in a parallel direction, which positions the actin-binding motifs close together [24, 40, 
41]. 
Fimbrin is an example of an actin-binding protein that contains 2 actin-binding motifs in 
a single monomer. Due to Fimbrin’s small size and the proximity of the two actin-binding 
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motifs, this positions the actin filaments in a bundle only ~5nm apart. The tighter packing of the 
F-actin bundle precludes myosin from interacting with the core of the bundle [21, 23, 25].  
These differences among ABPs are prime examples of how actin can be modified in 
different ways to suit different requirements. A tight knit bundle will be inherently stronger than 
a single filament and is necessary for the generation of force required to change a cell’s 
morphology [14, 18, 42]. More permanent structures such as those found in microvilli also 
require a denser actin bundle [24]. In contrast, deliberately spacing F-actin farther apart 
facilitates the interaction with myosin and contractile networks [18]. 
1.2.1.3  Translocation 
The third group of ABPs corresponds to the myosin family of proteins which are involved in 
translocation (Fig. 1.2C). While Myosin is typically thought of in the context of muscle cells, it 
is a large family of proteins that play many different roles with in a cell [18, 28, 29, 43-45]. For 
example in non-muscle cells, non-muscle MyosinII (nmMyoII) is phosphorylated and 
translocates along the F-actin filament generating force and contraction of F-actin filaments. This 
generation of force is central to the changes in cell morphology described in section 1.1. 
nmMyoII can work on actin bundles as well as single F-actin filaments, helping to generate 
strong mechanical force on a cell [18, 28, 29, 46]. Directed force generation is necessary for the 
anisotropic changes to cell morphology.  
 Other members of the Myosin family, notably MyoV, are involved in the transport of 
cargo through the cell along F-actin. This cargo can consist of vesicles, RNAs, or even 
organelles. MyoV’s motor component is different than that of MyoII, allowing it to “walk” along 
the actin filaments toward the minus end [43, 45].  
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1.2.1.4 Linking actin to the cell membrane 
The last group of ABPs are those that link F-actin to the cell membrane (Fig. 1.2E). These 
proteins are typically multi-domain scaffold proteins that are capable of binding to ether 
membrane lipids or the cytoplasmic portions of transmembrane proteins and to F-actin. 
Particularly important are the connections of F-actin to cell-cell junction complexes. For 
example, α-Catenin forms a complex that binds actin and links it to E-cadherin at adherence 
junctions [47-50]. Actin associated with cell-cell junction, such as adherence junctions, is critical 
for changes to a tissue shape, consistent with its role in remodeling cellular architecture [48, 51, 
52]. 
1.3 SHROOM/ROCK PATHWAY 
The Shroom/Rock pathway rearranges the cellular cytoskeleton through directed contraction of 
the actin network [6, 53, 54]. Different Shroom family members are expressed in different cell 
types and localize to unique areas of cells, consistent with the involvement of Shroom proteins in 
the proper development of the nervous system, sensory cells, eyes, vasculature, and gut [55-62]. 
All Shroom proteins effect change on the actin cytoskeleton by recruiting Rock to the 
cytoskeleton (Fig. 1.3) [63]. Once there, Rock activates nmMyoII, which in turn contracts the 
actin network, changing the shape of a cell and its neighbors [53, 64-66].  
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Figure 1.3: Working Hypothesis of the Shroom/Rock Pathway.  
Conserved across the Shroom family of proteins is the ability to localize to actin and recruit Rock to the 
cytoskeleton. Our data suggests that Shroom can directly activate Rock, which in turn activates non-muscle Myosin 
II, leading to actin contraction.  
1.3.1 The Shroom Family of Proteins 
The Shroom family can be found in most metazoans, from D. melanogaster to Humans [60]. 
Drosophila only has 1 copy of Shroom in the genome, dShroom, however there are several 
splice-variants that encode full-length (dShroomA) and N-terminally truncated versions 
(dShroom B and C) of the protein [67]. In contrast, mammals having four separate Shroom 
genes, Shroom1-4, that encode proteins that all have unique localization characteristics (Fig. 1.4) 
and are involved in different roles in development [60, 68]. I will focus on the mammalian 
version of the Shroom proteins for the rest of this document unless otherwise indicated.  
While each Shroom protein has a unique expression profile, there are several 
characteristic features that define the family (Fig. 1.5). They all contain a highly conserved C-
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terminal Shroom Domain 2 (SD2) that binds to Rock and subsequently recruits it to the 
actomyosin network [6, 63, 69-72]. Most members of the family also contain a centrally located 
Shroom Domain 1 (SD1). The SD1 is generally considered the actin-binding region, though a 
definitive actin-binding motif has not yet been elucidated for the Shroom family [57, 60, 68, 69]. 
The SD1 is less highly conserved across the family than the SD2. Finally, most Shroom proteins 
contain an N-terminal PDZ domain [69, 73]. While there is an NMR structure of Shroom4’s 
PDZ [73], there is no known function at this time for this domain in regards to Shroom activity. 
However, PDZ domains typically act as protein-protein interaction domains, suggesting that it 
may have a similar function for Shroom [74, 75].  
 
A                     Shroom2 B                     Shroom3 C                     Shroom4 
Shrm3/Ac)n	Shrm2/Ac)n	 Shrm4/Ac)n	  
 
Figure 1.4: Differential localization of Shroom family members in Fibroblasts.  
Rat Fibroblasts were transfected with expression vectors for Shroom2, Shroom3 or Shroom4 and stained to detect 
each protein. A) Shroom 2 localizes to cortical actin, B) Shroom3 localizes to actin stress fibers, C) Shroom4 
localizes to cytosolic actin punctae. Figure modified from Dietz et al. 2006 [68]. 
 
 11 
Localization 
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hShroom3 
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hShroom4 
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Figure 1.5: Domain map of the Shroom family of proteins.  
The Shroom family contains several conserved domains: PDZ, Serine Proline Rich (SPR), SD1, and SD2. They vary 
in length as well as tissue expression and subcellular locations, during development and in adult tissues. Figure 
adapted from S. Mohan and J. Zalewski.  
1.3.1.1  Shroom3 
Shroom3 has been studied more extensively than other members of the Shroom family. It was 
first discovered in a mouse genomic screen looking for genes responsible for neural tube 
development [69]. Shroom3 was named for its phenotype; the neural tube in Shroom3 mutant 
mice, mushrooms out instead of properly closing. While being the first protein to be named 
Shroom, it was found to be homologous to two other proteins already known to exist: Apical 
Protein Xenopus (APX), and APX Like (APXL) [69]. In the original study, Shroom3 was 
characterized as a PDZ containing, actin-binding protein [69]. Work from our lab and others 
further elucidated that Shroom3 localizes to the apical portion of cell-cell adhesion sites in 
epithelial cells to regulate apical constriction [6, 63]. Domain mapping studies of Shroom3 
indicated that the SD1 and SD2 motifs are both required for apical constriction. These studies 
showed that the SD1 is required for localization to actin and the SD2 is required for recruiting 
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Rock [6, 68]. Shroom3 and Rock are critical not only for neural tube closure but also for the 
extension of the body axis through convergent extension of cell layers [2, 53, 63, 71, 72]. When 
Shroom3 is ectopically expressed in fibroblasts it localizes to actin stress fibers across the cell 
(Fig. 1.4B). Shroom3’s SD1 has also been shown to co-sediment with F-actin in actin-binding 
experiments [69].  
When we look at Shroom3 in vivo, Shroom3 directly interacts with components of other 
pathways important to regulating cell morphology in different cell types, helping to specialize its 
role in development [2, 8, 61, 63, 76]. Previous work from our lab has shown that Shroom3 co-
localizes and co-sediments with the Dishevelled2 protein of the PCP pathway [2]. We believe 
this interaction helps to refine Shroom3 localization to the apical junctions of cells, where we 
know other members of the PCP pathway are located, such as Frizzled (Fig. 1.6A) [2]. In 
growing neurons, Shroom3 localizes to the base of axons and directly interacts with the Plenty of 
SH3 (POSH) protein (Fig. 1.6B). Once at the base of an axon, the Shroom3/Rock complex helps 
to regulate axonal outgrowth by inducing actin contraction within the axon [76, 77].  
1.3.1.2 Shroom2 
Shroom2 was originally classified as Apical Protein Xenopus Like, APXL, however it was 
renamed when the “Shroom” nomenclature was established [78]. Shroom2 is expressed in 
epithelial cells throughout the developing embryo, where it is involved in vasculature and gut 
morphogenesis, as well as in kidney development [59, 60, 68]. It can also be found in the sensory 
cells of the eyes (rods and cones) and inner ear (vestibular hair follicles) [57-59, 68]. Shroom2 
contains the N-terminal PDZ, central SD1, and C-terminal SD2 typical of the Shroom family. 
The SD2 is competent to recruit Rock to the actomyosin network. Shroom2 is also an ABP with 
a conserved SD1 that co-sediments with F-actin [57]. Shroom2 functions in much the same 
 13 
manner as Shroom3, however it is expressed in different tissues and localizes to different 
populations of actin. We have found that Shroom2 has a unique localization pattern when 
expressed in fibroblasts compared to Shroom3. Shroom2 localizes to cortical actin, where as 
Shroom3 localizes to actin stress fibers (Fig. 1.4A vs. B) [68]. One group has shown that 
Shroom2 directly interacts with ZO-1 and MyosinVIIa at adherens junctions (Fig. 1.6C) [57]. 
 
A B C
 
 
Figure 1.6: Shroom3 and Shroom2 localize differently with upstream proteins. 
Specialization of the Shroom family members may be achieved though localization with other upstream pathways 
and proteins. A) Shroom3 localizes and binds to Dishevelled2 (Dvl2) of the PCP pathway [2]. B) Shroom3 also 
localizes to POSH in developing neurons [76]. C) Shrm2 localizes with and directly bind ZO-1 and MyosinVIIa in 
sensory cells such as inner ear hair follicles [57]. 
1.3.1.3  Shroom4 
Shroom4 was originally designated as KIAA1202, but was later reclassified when the “Shroom” 
nomenclature was adopted [78]. It contains the N-terminal PDZ and C-terminal SD2, but it lacks 
a well-conserved SD1. There is some conservation between the central region of Shroom4, 
Shroom2 and Shroom3, though it is debatable if it truly has a complete SD1 [60, 78]. Shroom4 
does localize with cytosolic actin punctate when expressed in fibroblasts, and can bind actin in 
vitro [62, 68]. It is unclear if Shroom4 induces the formation of the actin punctae or if it localizes 
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to actin architecture already found in the cell. Mutations in SHROOM4 have been associated 
with X-linked mental retardation in humans [79]. 
1.3.1.4  Shroom1 
Shroom1 is the least well studied member of the Shroom family. Although it has some 
similarities to Apical Protein Xenopus (APX), it is likely unique to mammals [60, 78]. Shroom1 
is the smallest member of the vertebrate Shroom family at only ~850 amino acids. Shroom1 
lacks the N-terminal PDZ domain that is shared among the other Shroom family members and it 
is debatable if it actually contains a complete SD1 [55, 60, 78]; the conservation of the central 
region is so low among the family members, it makes defining the SD1 difficult. This will be 
discussed in section 1.4.2 in more detail. Shroom1 does contain a putative SD2 motif, but it has 
not been shown to bind Rock [55]. 
1.3.2 Rho Associated Coiled-coil Kinase 
Rock kinase activity is required for Shroom-induced change in cell morphology [53, 63]. Rock 
consists of 3 regions, an N-terminal Kinase domain, a central coiled-coil region, and a C-
terminal PH/C1 domain [63-65, 72, 80]. Rock forms a parallel dimer through its core coiled-coil 
region, with the dimerization domain located C-terminal to the Kinase domain. N-terminal to the 
coiled-coil region, the 2 copies of the PH/C1 domains fold independently of each other [81]. 
Within the coiled-coil region are two known protein binding domains, the Shroom Binding 
Domain (SBD), which binds Shroom’s SD2, and the RhoA Binding Domain (RBD), which binds 
the active form of the RhoA GTPase [65, 72, 80, 82-87]. While Rock has been shown to be 
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involved in actin regulation, it has never been shown that Rock directly associates with actin [64, 
65, 88, 89]. Thus, to regulate cytoskeletal changes, Shroom must recuit Rock to actin. 
1.4 SHROOM AND ACTIN 
Beyond binding Rock, the Shroom family proteins bind F-actin. This characteristic has been 
understood since the identification of Shroom. The SD1 region is responsible for binding actin 
[6, 68, 69]. Work from our lab and others has narrowed down the boundaries of the SD1 region 
responsible for actin-binding, but the interaction is still poorly understood [6, 57, 60, 68, 69]. 
The scope of this work will focus on the SD1 domain and its interaction with actin. 
1.4.1 Shroom’s Role as an Actin Binding Protein 
Since its characterization as a cytoskeletal protein, other aspects of Shroom’s role as an ABP 
have been investigated. Based on these studies, Shroom appears to have multiple ABP roles (Fig. 
1.2): First, Shroom has been shown to protect F-actin filaments in cells treated with Cytochalasin 
D treatment [68]. Cytochalasin D prevents the addition of new monomers to F-actin as well as 
preventing other ABPs binding to the barbed end. In this way Shroom plays a role in stabilizing 
filaments. Second, both Shroom2 and Shroom3 induces actin bundles in vitro [68] and Shroom3 
recruits and reorganizes actin in vivo. When ectopically expressed and artificially targeted to the 
mitochondria, Shroom3 recruits actin to this location [6, 68]. This characterizes Shroom as 
having a role in reorganizing actin architecture on multiple levels. Third the Shroom/Rock 
pathway is directly responsible for phosphorylating nmMyoII, and thus leading to translocation 
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of myosin along the filaments [6, 53, 54, 63, 90]. Finally, Shroom2 and Shroom3 directly 
interact with and cell membrane proteins (Shroom2, ZO-1 at adherence junctions) [57] 
scaffolding proteins (Shroom3, Dishevelled which binds Frizzled) [2]. Additionally, the PDZ 
domain of Shroom could bind additional currently unknown membrane proteins, as other PDZ 
domains are known to do [74, 75]. These different roles position Shroom family proteins as 
unique and complex ABPs. Despite this information, we still do not know how Shroom is able to 
bind actin or effect changes in actin architecture.  
1.4.2 SD1 
Shroom proteins regulate actin directly through binding and bundling of the actin filaments and 
indirectly through recruitment of Rock and the activation of nmMyoII. Previous work has 
focused on the indirect effect on the cytoskeleton. This work is focused on the biochemistry of 
Shroom/actin binding. The SD1, as previously mentioned, is found in most Shroom family 
members. While we describe it as a domain, it does not follow traditional definitions of a 
domain; it lacks unique predicted secondary structure such as that observed in the PDZ domain, 
and it also lacks clear boundaries based on sequence conservation [69]. Additionally, initial 
limited proteolysis experiments have not revealed a stable domain (data not shown). However, 
the SD1 acts as an individual domain in that it can successfully bind actin independent of the 
other domains of Shroom [6, 68].  
In an effort to better define the SD1, alignments of Shroom2, Shroom3 and Shroom4 
were analyzed. It was found that there are patches of conservation between Shroom 2, 3, and 4, 
as well as regions unique to only 1 or 2 family members (Fig. 1.7). Given their conservation, it is 
possible that these patches of similarity contain sequences responsible for both actin-binding and 
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bundling. Using this model, regions of the SD1 from mouse and human Shroom2 and Shroom3, 
containing different conserved elements, were expressed and purified from E. coli. The various 
SD1 proteins were used in the studies described in Chapter 2 to determine the function of each 
patch and significantly narrow down the sequences in the SD1 that mediate the actin-binding 
properties of Shroom proteins. 
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Figure 1.7: Conserved sequence motifs in the SD1s of Shroom2, Shroom3 and Shroom 4.  
A) Alignment of Human Shroom2 and Human Shroom3 SD1 regions (ClustalW and JalView). Three patches of 
conservation are boxed. B) Schematic representation of conserved patches for Shroom2, 3 and 4. While some 
regions are found across the whole family (light blue), other regions are only found within Shroom3 and Shroom2 
(blue). Individual Shroom proteins have regions that are conserved only in that Shroom family member (teal for 
Shroom2, purple for Shroom4).  Numbers represent approximate range represented of the Human isoform of each 
Shroom’s SD1 region.  
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1.5 GOALS OF THIS RESEARCH 
The aim of this research is to define the molecular basis for the Shroom-actin interaction and 
understand how this interaction influences actin architecture. Toward this end, we will use an 
entirely in vitro biochemical system including binding assays and electron microscopy, which 
will allow me to directly assess Shroom’s role in modifying actin dynamics. Finally, by using 
both Shroom2 and Shroom3 I can compare each of their SD1’s to identify a minimal conserved 
actin-binding domain.  
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2.0   SHROOM2 AND SHROOM3 ALTER ACTIN’S ARCHITECTURE WITH THE 
CONSERVED DOMAIN, SHROOM DOMAIN 1 (SD1) 
2.1 INTRODUCTION 
All Shroom proteins are characterized as actin-binding proteins. Previous work has shown that 
the actin-binding module of Shroom2 and Shroom3 are centered around the SD1 [55, 57, 62, 67, 
69]. Sequence analysis of this domain across the family reveals a patchwork of conserved amino 
acids. Evolutionary pressure has presumably led to the maintenance of these conserved patches. 
However, previous research has yet to determine how the Shroom family is able to mediate an 
interaction with actin. These patches provide a promising starting point for elucidating the 
minimal region of the SD1 required for actin binding. I have used proteins of the SD1 from 
human and mouse Shroom2 and Shroom3 that cover the various patches in an effort to determine 
a minimal functional region for actin binding. 
As mentioned earlier, previous work from our lab has shown that Shroom3 is able to 
modify actin’s architecture [68]. It is not known if Shroom2 or other members of the Shroom 
family also have this ability. Additionally, the exact nature of how Shroom3 binding alters the 
organization of F-actin is not known. To this end I have employed transmission electron 
microscopy to begin to understand what Shroom’s SD1 is doing to actin at a structural level. The 
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goals of this work are to 1) define a minimal region for actin binding and bundling, and 2) define 
the nature of the actin bundles induced by the SD1 at a structural level. 
2.2 RESULTS 
2.2.1 Purification of Shroom2 and Shroom3 SD1 proteins 
To date, the minimal domain of the SD1 has not been determined biochemically. To further 
analyze the Shroom family’s ability to bind actin and change the architecture of actin filaments, 
as our previous data suggests [68], I expressed and purified a variety of SD1 protein deletion 
constructs from mouse Shroom2, human Shroom2, and mouse Shroom3. These proteins covered 
different portions of the predicted SD1 (Fig. 2.1) with various tags to assist in purification. All 
constructs contained 6x or 10x His tags and a TEV cleavage site for tag removal. The constructs 
designed from human Shroom2 also contained a fluorescent Ruby tag that could also be removed 
with TEV protease. Finally the human Shroom2 constructs also contained C-terminal Arginine 
hooks. Details about the constructs used can be found in the Materials and Methods, sections 4.1, 
Table 1. These initial proteins will allow us to begin to determine the minimal SD1 based on 
conserved patches.  
I transformed the corresponding expression plasmids into E. coli RIPL cells and induced 
expression using the auto-induction method [91]. Shrm2A_E, Shrm2B_E, Shrm3BCD, and 
Shrm3CD were poorly expressed relative to other Shroom domains (Fig. 2.2 & 2.4). In contrast, 
the Ruby-Shrm2A_D and Ruby-Shrm2CD proteins were expressed robustly (Fig. 2.3) and the 
Ruby tag appeared to help with solubility. This may prove useful in the design of future SD1 
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expression plasmids. All of the SD1 proteins exhibit significant degradation (Fig. 2.2, 2.3, and 
2.4 elution lanes), however all SD1s were more stable when lysed in pH 8 buffer. Shrm3BCD 
degraded significantly more than Shrm3CD (Fig. 2.4A vs. B elution lanes). Generally, the 
shorter proteins (Shrm2B_E, Shrm2CD, and Shrm3CD) were more stable than the longer SD1 
proteins (Shrm2A_E and Shrm3BCD). The increased degradation of the larger proteins and 
increased stability of the smaller proteins supports the hypothesis that there is a stable domain 
contained within the purified proteins.  
  
Figure 2.1: The SD1 proteins used in this work.   
These proteins were designed and cloned by Ryan Corbo (Shrm2A_D & Shrm2CD) and Ryan Rizaldy (Shrm3BCD, 
Shrm3CD, Shrm2A_E, & Shrm2B_E). Shrm2A_D & Shrm2CD are derived from human Shrm2 and the 
Shrm3BCD, Shrm3CD, Shrm2A_E, & Shrm2B_E are from mouse Shrm3 and Shrm2. All proteins contain a 6x or 
10x Histidine tag for purification. The Shrm2A_D and Shrm2CD proteins also contain a fluorescent Ruby tag at the 
N-terminus and an arginine hook at the C-terminus. His and Ruby tags can be removed by TEV cleavage.  
 
All of the proteins could be purified with similar conditions laid out in the materials and 
methods section 4.2. Shrm2A_E had two prominent degradation products (Fig. 2.2A) that co-
purified and contributed to subsequent biochemical assays (Fig. 2.8A). This suggests there may 
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be a stably folded domain in the purified proteins. Shrm2B_E initially degraded very quickly 
during purification, however this was rectified by adjusting the lysis buffer to pH 8 (data not 
shown). Shrm2CD was sufficiently pure after a single Ni-column to be used for further assays 
(Fig. 2.3). Ni-column flow through, washes, and elution fractions for each purification of an SD1 
were run on 12% SDS-PAGE. The gels were then assayed with Coomassie stain to visualize total 
protein present.   
Once the tags were removed, the proteins were run through an additional Ni-column 
purification. Following Ni-column chromatography, all of the SD1 proteins were diluted into a 
low salt buffer for cation-exchange chromatography. Elution fractions were analyzed by SDS-
PAGE and Coomassie staining for total protein (Fig. 2.2, 2.3, & 2.4 cation-exchange gels). 
Shrm2A_D eluted later than most of the degradation products when eluted with a sufficiently 
shallow gradient of NaCl (Fig. 2.3A, cation-exchange). This could be explained if the 
degradation products lack the arginine hook. The degradation products eluted around 200mM 
NaCl, similar to that of the other SD1 proteins that did not contain an arginine hook, helping to 
support this hypothesis. 
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Figure 2.2: Purification of Shrm2A_E and Shrm2B_E.  
E. coli were harvested by centrifugation, resuspended in lysis buffer and lysed by homogenization. Cleared 
supernatant was bound to Ni-sepharose, washed and bound proteins eluted with imidazole. Proteins were further 
purified with cation-exchange chromatography. A) Ni chromatography and cation-exchange chromatography of 
Shrm2A_E. Fractions 15-19 were collected and concentrated for use in actin binding and bundling assays.  B) Ni 
chromatography and cation-exchange chromatography of Shrm2B_E. Fractions 15-18 were collected for further 
assays. Samples were run on 12% SDS-PAGE for 55 mins at 200V and total protein was visualized with Coomassie 
stain. 
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Figure 2.3: Purification of Shrm2A_D and Shrm2CD.  
Bacteria were harvested by centrifugation, resuspended in lysis buffer and lysed by homogenization. Cleared 
supernatant was bound to Ni-sepharose, washed and bound proteins eluted with imidazole. Proteins were further 
purified with cation-exchange chromatography. A) Shrm2A_D Ni-column chromatography and Cation-exchange 
chromatography following TEV digest (to remove the Ruby and His tags) and second Ni-column chromatography. 
Fractions 21-26 were collected and concentrated for F-actin bundling experiments. B) Ni chromatography of 
Shrm2CD. Samples were run on 12% SDS-PAGE for 55 mins at 200V and total protein was visualized with 
Coomassie stain.  
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Figure 2.4: Purification of Shrm3BCD and Shrm3CD.  
E. coli were harvested by centrifugation, resuspended in lysis buffer and lysed by homogenization. Cleared 
supernatant was bound to Ni-sepharose, washed and bound proteins eluted with imidazole. Proteins were further 
purified with cation-exchange chromatography. A) Ni-column purification of Shrm3BCD of lysed cells, B) Cation 
exchange column of Shrm3BCD. Fractions 19-23 from the Cation-exchange column were for further experiments C) 
Ni-column purification of Shrm3CD from cells lysed by homogenization. D) Cation-exchange column of Shrm3CD. 
Fractions 17-20 were collected. Samples were run on 12% SDS-PAGE for 55 mins at 200V and total protein was 
visualized with Coomassie stain. 
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After cation-exchange chromatography, the rest of the SD1s were sufficiently pure of 
contaminants to be used in actin-binding assays. Ruby-Shrm2 (Shrm2A_D and Shrm2CD) 
proteins were either used for assays immediately following the 1st Ni column, or the Ruby and 
His tags were removed with TEV proteolysis. While it is possible to concentrate the various 
SD1s proteins using centrifugal concentrators, I found that a large portion of protein was lost 
during the process. It is possible that aggregated SD1 bound to the membrane of the 
concentrators and was not recovered. I predict that the SD1 is susceptible to aggregation or 
precipitation if buffers are changed drastically and I found that they all have a propensity to 
degrade (Fig. 2.2, 2.3, and 2.4). Therefore, if possible, elution fractions from the cation-exchange 
columns were used directly for binding and microscopy studies. 
2.2.2  Minimal domain of SD1 still capable of binding actin  
Previous work from our lab examined Shroom/actin interactions using a co-sedimentation assay 
[68, 69]. As an example, I repeated this experiment with a minimal SD1 protein that had not 
been used in the previous study, Shrm3CD (Fig. 2.1). This protein contains only two conserved 
patches, but these patches are common to all of the SD1 proteins tested. Purified Shrm3CD was 
incubated with F-actin at room temperature for 30 minutes and the samples were then 
centrifuged at 160,000xg. This speed pellets all F-actin and, subsequently, any actin-binding 
protein present in the sample [92, 93]. When Shrm3CD is pelleted in the absence of actin, 
approximately 60% of it is found in the pellet. However, in the presence of F-actin, all of 
Shrm3CD is found in the pellet (Fig. 2.5). This supports our previous data that the SD1 is the 
actin-binding domain of Shrm. As Shrm3CD is the smallest SD1 construct I tested, these results 
reduce the boundaries of the actin-binding domain to amino acids 900-1100. 
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Figure 2.5: A minimal SD1 binds to actin.   
Shrm3CD co-sediments with F-actin when the reactions are pelleted at 160,000xg. It also increases the ratio of actin 
in the pellet compared to actin alone. 
2.2.3 Shroom2 and Shroom3 SD1s localize to actin bundles 
As an additional test of Shroom/actin interactions, I used confocal microscopy to show that the 
SD1 proteins not only co-sediment with actin, but also co-localize with actin. I used the same 
binding reactions as used for the co-sedimentation assay with Shrm3CD, Shrm3BCD and Ruby-
Shrm2CD. The Shroom-actin reactions were stained with Phalloidin (F-actin) or α-Shroom3 
antibody, spotted on slides, and imaged by confocal microscopy (see Materials and Methods 
Section 4.4). For Shroom2-actin complexes, Shrm2CD was detected using the Ruby tag. F-actin 
alone (Fig. 2.6C) or in the presence of BSA (negative protein control, Fig. 2.6A) remains as 
single filaments and small aggregates. However, when mixed with either Shroom2 or Shroom3’s 
SD1, F-actin aggregates and bundles. These bundles co-stain for Shroom (Fig. 2.6 B”, D” & E”). 
This suggests that Shroom is not only binding actin, but also modifying actin’s architecture. 
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Figure 2.6: Shroom SD1 localizes to F-actin bundles.  
A-A’’) F-actin with BSA, B-B’’) 5µM F-actin plus 5µM Ruby-Shrm2CD. F-actin bundles in the presence of 
Shrm2CD, C-C’’) F-actin, D-D’’) F-actin plus Shrm3BCD, E-E’’) F-actin + Shrm3CD, A-E: Phalloidin Alexa-488 
(1:1000), A’ & B’: Ruby-tag fluorescence, C’-E’: αShroom3, A”-E”: Merge 
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2.2.4 Shroom2 and Shroom3 SD1 induce actin bundles at similar concentrations 
My previous experiments using confocal microscopy suggested the SD1 functions to bind and 
bundle actin. All Shroom proteins are actin-binding proteins, and it appears that Shroom may 
play a role in changing actin’s organization both in vitro and in vivo [68]. My work has mainly 
focused on investigating Shroom2 and Shroom3 SD1s’ ability to bundle actin in vitro. This work 
will begin to draw a biochemical and structural picture of how Shroom acts as an actin-binding 
protein. To assess the capacity of the various SD1 proteins that I purified to bundle actin, I 
utilized a simple assay that relies on differential sedimentation of actin filaments verses actin 
bundles. When a solution of F-actin is centrifuged at 14,000xg only bundled F-actin will pellet, 
whereas G-actin and single filaments will remain in the supernatant [93]. These assays will also 
co-sediment proteins that are bound to the actin bundles. An increase in the amount of bundled 
actin in the pellet when SD1 is added would suggest that the SD1 is responsible for actin 
bundling by Shroom.  
Initially all proteins were tested with Shroom in excess to determine the absolute ability 
of each protein to bundle F-actin. All SD1 proteins I worked with were capable of bundling 
actin. For example when mixed with Shroom3 SD1 (Shrm3BCD or Shrm3CD), approximately 
80% of the F-actin pellets following low-speed centrifugation (Fig. 2.7).  
Repeating this experiment with the additional SD1 proteins from Shroom2 and Shroom3 
induced bundling of approximately 50% of the actin present with µM affinity (50% of 5uM of F-
actin was bundled by 0.5µM to 1µM Shroom SD1) (Fig. 2.8).  This ratio held true even for the 
smallest SD1 proteins for both Shroom2 and Shroom3 (Shrm2CD and Shrm3CD) (Fig. 2.8 D 
and E). The exact ratios of bundled to unbundled actin had a degree of variability (Fig. 2.8, % of 
F-actin in the pellet).  
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Figure 2.7:  Shroom3 SD1 bundles F-actin.  
Addition of Shrm3BCD (A) or Shrm3CD (B) induces bundling of actin in vitro. Shrm3CD is more stable than 
Shrm3BCD, which degrades. This could suggest that Shrm3CD represents the stable domain. Reactions were run on 
12% SDS-PAGE for 50 minutes at 200V and total protein was visualized with Coomassie stain. 
 
The actin binding reactions were also run for varying lengths of time in addition to 
varying the concentrations of SD1 then. I found that within 10 minutes, 1µM Shroom SD1 was 
sufficient to bundle F-actin to a similar degree as the 30-minute standard reaction. When Shroom 
is in excess, the shortest time point (less than 1 minute) was sufficient to bundle F-actin to the 
same level as the standard 30-minute reaction (data not shown). 
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Figure 2.8: Shroom2 and Shroom3 induce bundling of F-actin with nM affinity.  
Varying concentration of the indicated Shroom2 or Shroom3 SD1 proteins were added to a fixed amount of F-actin, 
incubated for 30 minutes at room temperature and centrifuged for 1hr at room temperature at 14,000xg. A) 
Shrm2A_E, B) Shrm2B_E, C) Shrm2A_D, D) Shrm2CD, E) Shrm3CD 1uM to 4uM, E’) Shrm3CD 50nM to 2uM. 
2.2.5 Shroom2 and Shroom3 SD1s induce the formation actin bundles with similar 
architecture. 
I established that all of the tested SD1 proteins are capable of inducing actin bundling (Fig. 2.7 
and 2.8). However, since the bundling assay only assesses the formation of large structures, it 
was not known if these proteins induce the formation of bundles with the same architecture or 
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organization. Given that these two family members localize to different actin populations, with 
different architectures, it is possible that the SD1s of Shroom2 and Shroom3 order the actin 
fibers differently.  
Historically, EM has been a common method for visualizing actin as well as actin-
binding proteins at nm resolution [12, 15, 46, 94-96]. The ability to visualize individual filaments 
removes the need for molecules to pack in a regular lattice as required by x-ray crystallography. 
Additionally, F-actin filaments themselves are not always ordered the same way within a bundle 
and thus would not be uniform enough to achieve ordered diffraction. Another thing to consider 
when dealing with the bundling of actin is that one bundle may not, and likely variability will not 
be, exactly the same as another bundle. Differences in the number of F-actin filaments forming 
the bundle, and uneven distribution of the actin-binding protein both contribute to the difficulty 
in understanding these complex structures at an atomic scale. To date there are no published 3D 
reconstructions of an actin bundle formed in vitro. Current models are based on structures of 
single F-actin filaments bound by actin-binding proteins [97-99]. However, to achieve these 
structures, either actin or the actin-binding proteins had to be modified so as not to form actin 
bundles [46, 96]. To accomplish my goals, I first had to understand qualitatively the architecture 
of the SD1-induced F-actin bundles.  I used this information to formulate hypotheses about how 
the SD1 induces the formation of the F-actin bundles. 
Toward this end, I used Transmission Electron Microscopy (TEM) to further analyze the 
structure of the F-actin bundles formed in the presence of the Shroom SD1s. To generate samples 
for TEM analysis, actin bundles were generated as described in the previous section, however 
samples were immediately spotted on grids and negative stained. Using a floating carbon method 
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to make the grids, developed by Dr. Duda (see Materials and Methods), greatly reduced the 
background noise as compared to those grids that were pre-coated in carbon.  
The SD1 proteins of Shroom2 and Shroom3 induce bundles (Fig. 2.9). The SD1 proteins 
from Shroom2 and Shroom3 induce the formation of actin bundles that have roughly the general 
appearance of parallel or anti-parallel bundles of highly-packed filaments, ranging from a few 
filaments (15nm in width) to many filaments (~100nm in width) (Fig. 2.9). For example, 
Shrm2A_D, one of the longest SD1 proteins containing all of the core elements, induced the 
formation of bundles with an architecture similar to those induced by Shrm3CD, one of the 
shortest, most minimal SD1 proteins (Fig. 2.9D and 2.9G) This observed similarity suggests that 
conserved patches C and D may constitute the minimal SD1 and confer Shroom’s ability to bind 
and bundle actin. The high level of variability between bundles, even within the same sample, 
can likely be attributed to the fact that forming bundles is a dynamic process and with EM we are 
able to see every stage of bundle formation. We can see bundles that may represent the early 
stages of actin-bundling consisting of only a few filaments (Fig. 2.9E), to the more organized, 
larger, possibly later stages of bundling (Fig. 2.9G).  
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A                      F-actin B     F-actin + Shrm2A_E C     F-actin + Shrm2B_E 
D     F-actin + Shrm2A_D E     F-actin + Shrm2C_D 
F     F-actin + Shrm3B_D G    F-actin + Shrm3C_D 
 
 
Figure 2.9: Shroom induced actin bundle formation.  
F-actin or F-actin plus the indicated SD1 proteins were mixed at room temperature for 30 minutes, spotted on grids, 
and observed via TEM. All SD1 proteins tested induced the formation of bundles with a range of diameters. A) F-
actin alone, B) F-actin with Shrm2A_E, C) F-actin with Shrm2B_E, D) F-actin with Shrm2A_D, E) F-actin with 
Shrm2CD, F) F-actin with Shrm3BCD, G) F-actin with Shrm3CD.  
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To more precisely define bundling structure, we analyzed several of our micrographs. For 
example, Shrm2A_E induced a small bundle of actin that had a very regular pattern (Fig. 2.10) 
that forms a repetition between a narrow region and a wider region. To analyze these bundles 
further I utilized Fast Fourier Transforms (FFT) to enhance the images (see Materials and 
Methods 4.6 and Appendix B). When looking at the inverse FFT, we can see that this structure is 
likely composed of two F-actin filaments next to each other. The bulbous point that we see in the 
original image likely reflects the cross over point of F-actin: the spacing of these points is 
approximately 365Å, as is more apparent in the inverse FFT, which correlates with the known 
cross over spacing for an F-actin filament (360Å). The distance between filaments is 
approximately 5nm. Repeated attempts to replicate the exact same bundle shape produced a 
range of actin bundle sizes, some very similar to that seen in 2.10A. It is possible this small 
bundle, which likely consists of only 2 actin filaments, based on the total width measurement of 
each filament (6.5nm) and the inverse FFT (Fig. 2.10B), is a precursor bundle to some of the 
larger bundles we also observe. Because of its highly ordered structure we have also pursued 
Cryo-EM of the actin bundles formed by this SD1. We have successfully frozen grids that 
contain the actin bundles of various sizes (Fig. 2.10C). Our collaboration with the Conway lab in 
the Department of Structural Biology will hopefully lead to a 3D reconstruction of the actin 
bundle formed in vitro.  
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Figure 2.10: Shrm2A_E induced actin bundles. 
A) Ordered F-actin bundle of F-actin with Shrm2A_E, B) The inverse FFT shows that the right bundle is likely 
made up of 2 parallel F-actin filaments, C) TEM of preliminary Cryo-EM grid with F-actin bundles induced by 
Shrm2A_E. We can see a wide range of sizes of bundles and the filaments of actin look well ordered. 
 
Closer examination of a bundle formed by Shrm2B_E, a protein that encompasses almost 
the entirety of the predicted Shroom2 SD1, and a bundle of the same size formed by the most 
minimal region of the Shroom3 SD1, Shrm3CD, reveal several similarities (Fig. 2.11). If we 
preform a Fast Fourier Transform (FFT) on a segment of the bundle, and trim the data to remove 
artifacts from the microscope, we can calculate an inverse FFT of this data (see appendix B). As 
we can see in Fig. 2.11, comparing A’ and B’ indicated strong similarity to the spacing of the F-
actin filaments. Also, the filaments are packed in parallel or anti-parallel bundles.  
Taken together, these data suggest several interesting properties of the SD1. First, they 
suggest that the minimal functional SD1, at least for actin bundling, consists of the conserved 
	 100nm 
C Cryo-EM of F-actin + Shrm2A_E A F-actin +          
   Shrm2A_E 
B inverse  
    FFT 
~365Å	
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core elements C and D. Second it suggests that the actin bundles induced by the SD1 consist of 
parallel or anti-parallel bundles, as opposed to a mesh or some other higher order network. Third, 
it suggests that the other conserved sequence elements may be involved in other aspects, such as 
regulation.  
 
 
Figure 2.11 Shroom2 and Shroom3 induce the formation of actin bundles with similar architecture.  
A) TEM of a F-actin bundle induced by Shrm2B_E. A’) Inverse FFT of this bundle. We can see the separation of 
the F-actin filaments more clearly once the data has been trimmed. B) TEM of a F-actin bundle induced by 
Shrm3CD B’) Inverse FFT of the bundle. Given that the starting image was more in focus, it contained more data. 
This increase in data allows more information to be apparent in the inverse FFT. The light lines are the F-actin 
filaments, the dark gaps are the spaces between filaments. 
A B A’ B’ 
							TEM																													Inverse	FFT	
F-ac/n	with	Shrm2B_E	
							TEM																													Inverse	FFT	
F-ac/n	with	Shrm3CD	
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3.0   DISCUSSION AND FUTURE DIRECTIONS 
3.1 ACTIN BUNDLING IS CONSERVED BETWEEN SHROOM2 AND SHROOM3 
We show here that Shroom is a potent actin bundling protein, capable of bundling actin in lower 
concentration ratios than that of Villin, an actin-binding that protein that forms bundles of similar 
architecture. For comparison, Villin reached maximal bundling at a ratio of 1.5µM Villin to 3µM 
F-actin [41]. The Shroom SD1s I tested reached maximal bundling at around 1.5µM SD1 to 5µM 
F-actin. Shroom SD1s were able to induce bundling of 50% of the F-actin at molar ratios as low 
as 250nM SD1 to 5µM F-actin. This ratio could help us to hypothesize about occupancy of 
Shroom along F-actin filaments and bundles. It is possible that Shroom is more dispersed across 
the bundle than has been predicted and modeled for Villin and Fimbrin [23, 41, 97].  
In comparing Shroom’s actin bundles to those formed by Villin and Fimbrin, we see 
similar spacing of filaments, around 4.5-5nm [24, 25, 97]. This small spacing helps us to 
understand how Shroom bundles actin. We can rule out a scenario such as that of α-Actinin 
which dimerizes in such a manner to space the filaments approximately 30nm apart [26]. While 
the spacing between filaments is similar in Shroom-induced bundles and Villin- or Fimbrin-
induced actin bundles, there are differences. As discussed above, Shroom reaches maximal 
bundling of actin at a lower molar ratio than that of Villin. I was able to induce the formation of 
ordered bundles of actin up to 100nm in diameter. There is some evidence that Villin is also 
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capable of forming large bundles in vitro, supporting the biological relevance of bundles of this 
size. Villin and Fimbrin provide us two possibilities for how Shroom is able to bundle actin. The 
SD1 either forms a dimer that positions the two actin-binding motifs in close proximity (similar 
to Villin), or it contains two actin-binding motifs in close proximity (Fimbrin). 
Taken together, we conclude that Shroom likely plays a powerful role in regulating 
actin’s architecture during morphogenesis. For the anisotropic changes to cell shape to be 
achieved it would be beneficial for Shroom to easily induce the formation of actin bundles while 
also recruiting Rock to the actomyosin network. This bundling of actin by Shroom could also 
play into the regulation of Rock by Shroom and the subsequent regulation of myosin activity on 
the actin bundles themselves. Through bundling actin, Shroom levels could be increased in 
localized areas, leading to localized upregulation of Rock. As our research continues, it appears 
that this pathway feeds back on itself with multiple levels of regulation affecting multiple 
aspects. On one level, Shroom acts a scaffold between actin and Rock as well as other upstream 
proteins, like Dishevelled [2]. On another level, Shroom regulates the activity of Rock as well as 
the architecture of actin. Shroom appears to play a complex role in regulating changes to cell 
morphology. 
3.2 FUTURE DIRECTIONS 
The next steps of this project will be to define the actin-binding and/or dimerization motif(s) 
located within the minimal region of the SD1. There are a variety of actin-binding proteins, as 
well as the myriad of actin-binding motifs [22, 27, 100]. Many of these actin-binding proteins or 
protein families contain a unique actin-binding motif. This seems to be the case for Shroom as 
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well. Now that I have determined a minimal actin-binding/bundling region, we can investigate 
important residues for these activities. With this smaller region, we should focus on the most 
well-conserved amino acids of the two patches. Once an actin-binding motif is found, we can 
look in the Shroom family members that have been less well studied, and search for the same 
motif. We can use the fact that there is little conservation across the whole family to look for 
invariant residues as possible targets. 
With this work we are left with 2 possible models for how Shroom is able to both bind 
and bundle actin. Shroom either contains a single actin-binding motif, then dimerizes in an 
orientation that spaces the sites around 4.5 nm apart, or Shroom contains two actin-binding sites. 
To this end, mutational analysis of single patches could reveal highly informative separation of 
function variants, which can bind but not bundle or still form multimers and not bind actin. It 
would be interesting to see if each conserved patch were able to bind actin alone, or if each has 
it’s own role and they are not redundant. The oligomeric state of Shroom has been a point of 
interest for us since our collaborators solved the structure of the dShroom SD2 revealing an anti-
parallel dimer [70]. However, the structure of human Shroom2’s SD2 bound to Rock’s SBD 
recently solved by Jenna Zalewski suggests that the human Shroom2 SD2 binds Rock as a 
monomer (unpublished work). This dichotomy leaves the question of Shroom’s oligomeric state 
unresolved. To determine if the SD1 is a monomer or some higher order oligomer, a crosslinking 
assay could be done.  
Finally given the potential of Shroom to induce regular bundles in vitro, it provides a 
promising target for Cryo-EM with the goal being the first 3D reconstruction of an in vitro actin 
bundle. The architecture of the bundles formed by Shroom2 and Shroom3 are so similar that a 
model could be applied to both family members. This reconstruction would give us a new level 
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of understanding of what is happening within the cell on a structural level. Cryo-EM has proved 
to be the method of choice for structures of F-actin and F-actin in complex with ABPs [12, 15, 
23, 25, 95, 97]. We have preliminarily made Cryo-grids that contain actin bundles induced by 
Shroom, suggesting this may be a feasible approach. We hope to use this approach in the future 
to not only determine Shroom’s occupancy of the actin filaments, but also if Shroom is 
modifying the helical pitch of F-actin. It has been shown in other cryo-EM reconstructions that 
F-actin can be found with different helical pitches and polymorphisms. Finally, we hope to be 
able to solve the structure of the SD1 bound to F-actin as well as a 3D reconstruction of an in 
vitro formed actin bundle. 
 
A B 
 
 
Figure 3.1: Possible models for Shroom’s method of bundling actin.  
A) Shroom could contain 2 actin-binding motifs and span 2 f-actin filaments. B) Or Shroom could form a dimer and 
each monomer of Shroom would contain 1 actin-binding motif. The dimer of Shroom would bind multiple F-actin 
filaments to induce bundling.  
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4.0  MATERIALS AND METHODS 
4.1 PLASMIDS 
Table 1: Plasmids used in these studies 
Name  
(previous name) 
cDNA 
source 
Amino 
Acids 
Vector Tags contained Cleavage site Cloned by 
Shrm2A_E 
(mShrm2 573-921) 
Mouse 
Shroom2 
573-921 pET 151 
[101] 
N: 6xHis TEV site after 
6xHis 
Ryan 
Rizaldy 
Shrm2B_E  
(mShrm2 626-921) 
Mouse 
Shroom2 
626-921 pET 151 
[101] 
N: 6xHis TEV site after 
6xHis 
Ryan 
Rizaldy 
Shrm2A_D  
(hShrm2 565-843) 
Human 
Shroom2 
565-843 pXH2 
10xHis 
Ruby 
[102] 
N: 10xHis & 
Ruby; 
C: Arginine 
Hook 
TEV site after 
Ruby 
Ryan Corbo 
Shrm2CD  
(hShrm2 669-843) 
Human 
Shroom2 
669-843 pXH2 
10xHis 
Ruby 
[103] 
N: 10xHis & 
Ruby; 
C: Arginine 
Hook 
TEV site after 
Ruby 
 
Ryan Corbo 
Shrm3B_D  
(mShrm3 750-1100) 
Mouse 
Shroom3 
750-1100 pET 151 
[101] 
N: 6xHis TEV site after 
6xHis 
Ryan 
Rizaldy 
Shrm3CD  
(mShrm3 900-1100) 
Mouse 
Shroom3 
900-1100 pET 151 
[101] 
N: 6xHis TEV site after 
6xHis 
Ryan 
Rizaldy 
4.2 PROTEIN PURIFICATION 
SD1 proteins of mShrm2, mShrm3 and hShrm2 were purified from RIPL E. coli cells. Briefly; 
DNA was transformed into BL21 RIPL cells and grown overnight at 37C to saturation. 
Overnight culture were used to inoculate 1-2 L cultures and protein expression achieved via 
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auto-induction for approximately 24 hrs at RT. Bacteria was pelleted for 10 minutes at 6000xg, 
flash frozen in liquid nitrogen, and stored at -80°C until lysis. Cells were resuspended in lysis 
buffer (500mM NaCl, 25mM Tris-Base, 8% Glycerol, 5mM Imidazole, 1mM βME, pH 8) plus a 
protease inhibitor cocktail. Bacteria were resuspended with a ratio of 10 mg of cells per 1 mL of 
lysis buffer. Bacteria were lysed via homogenization using an Avestin Emulsiflex homogenizer. 
Insoluble material was removed via centrifugation for 30 minutes at 12,000xg. The supernatant 
was run over a Ni2+-column to allow for purification of his-tagged proteins. The column was 
sequentially washed with Lysis Buffer, Lysis buffer containing 1M NaCl, Lysis Buffer with 
15mM Imidazole, and then Lysis Buffer with 20mM Imidazole. His-tagged protein was eluted 
with either 200mM Imidazole buffer (mShrm2 and mShrm3) or 1M Imidazole buffer (Ruby-
hShrm2). The higher concentration of imidazole was necessary to release the 10xHis tag of the 
Ruby-hShrm2 proteins. Results were analyzed by SDS-PAGE and total protein was visualized 
with Coomassie stain.  
The 6xHis tag was not removed from the mShrm2 and mShrm3 proteins because 
skipping the TEV cleavage step reduced the degradation of the proteins by shortening the total 
purification time. The Ruby-hShrm2 proteins were more stable and were able to be treated with 
his tagged TEV protease to remove the Ruby and His tags. Cleavage reactions were run over a 
second Ni-column to separate free hShrm2 SD1 from the Ruby tag and TEV. The appropriate 
fractions from the Ni-columns were diluted into a low salt buffer (final NaCl concentration of 
100mM, pH 7.5) and run over a cation-exchange column to purify away contaminating proteins.  
Ruby-Shrm2 (Shrm2A_D and Shrm2CD) proteins were either used for assays 
immediately following the 1st Ni column, or the Ruby and His tags were removed with TEV 
proteolysis. Once the tags were removed, the proteins were run through an additional Ni-column 
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purification. The cleaved SD1 proteins flowed through and the un-cleaved fusion protein, the tag, 
and TEV (which itself has a His tag) remained on the Ni-column. Following Ni-column 
chromatography, all of the SD1 proteins were diluted into a low salt buffer (100 mM NaCl, 20 
mM Tris, 8% Glycerol, 1mM βME, pH 7.5) for cation-exchange chromatography. All proteins 
would precipitate if left to dialyze into a low salt buffer for too long. For this reason, the salt and 
pH had to be lowered by dilution instead of dialysis. To further minimize the propensity of the 
SD1s to precipitate, I increased the glycerol concentration from 2% to 8%, increased the pH 
from 7 to 7.5, and made the final salt concentration 100mM instead of 50mM. The Shrm2A_D 
and Shrm2CD proteins also possess an arginine hook, which aids in purification via cation-
exchange chromatography even at pH 8. The SD1s were eluted off the cation exchange with a 
gradient of increasing salt concentration. Shrm2A_E, Shrm2B_E, Shrm3BCD, and Shrm2CD 
eluted between 200mM and 300mM NaCl, owing to their similar pIs. The Shrm2A_D and 
Shrm2CD proteins eluted between 350 and 450mM NaCl due to their increased affinity for the 
cation-exchange because of the arginine hook 
4.3 ACTIN  
4.3.1 Actin Polymerization 
Actin (catalog number: AKL95) was polymerized into F-actin as described by the manufacturer 
(Cytoskeleton, LLC). Briefly; G-actin lyophilized powder was resuspended in 250µL of General 
actin Buffer (GAB, 5mM Tris, 0.2mM CaCl2, pH8) to 1mg/mL. Allowed to incubate on ice for 
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30 minutes. 25µL of  100mM ATP was added to induce polymerization of G-actin into F-actin 
[92, 93]. Final actin stock concentration 21µM. 
4.3.2 Actin Binding Reaction 
5uM actin was allowed to react with the purified SD1 proteins at various concentrations in GAB 
for 30 minutes at room temperature (RT). For control reactions, actin was either left alone or 
allowed to react with 1µM BSA. The reactions were then used for the following experiments. 
4.3.3 Analysis of actin Binding or Bundling via Differential Centrifugation 
Analysis of actin binding and bundling was performed as described by manufacturer 
(Cytoskeleton, LLC). For actin-binding, F-actin was mixed with purified SD1, incubated at RT, 
and centrifuged at high speed (160,000xg in a Beckman airfuge for 1 hour). At this speed, all the 
F-actin is pelleted and G-actin remains in the supernatant [92, 93, 104]. The supernatant was 
removed from the pellet and the pellet was resuspended in an equal volume GAB and 10x SDS 
Sample buffer added to a final concentration of 1x. Samples were analyzed by SDS-PAGE and 
total protein was visualized with Coomassie stain. 
To assay F-actin bundling, the actin binding reactions were spun at a low speed as 
described by the manufacturer (Cytoskeleton, LLC) to pellet bundled F-actin and the associated 
actin bundling proteins. The reactions were centrifuged at 14,000xg for 1hr [104]. The 
supernatant was removed from the pellet and the pellet was resuspended in an equal volume 
GAB and 10x SDS Sample buffer added to a final concentration of 1x. Samples were analyzed 
by SDS-PAGE and total protein was visualized with Coomassie stain. 
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4.4 CONFOCAL MICROSCOPY OF ACTIN BUNDLES 
Shrm3 SD1 proteins were allowed to react with actin, as described above. The reactions were 
incubated with a mixture of mShrm3 antibody (UPT132, [6]), Alexa568-conjugated secondary 
antibody (A-11036, Invitrogen), and Alexa Fluor 488 Phalloidin (A-12379, Thermo Fisher) (1µL 
of each in 10µL total master mix, 1µL of mix per reaction). Additionally due to the inability to 
wash away unbound antibody, the reactions were diluted 1:1 in mounting medium. This greatly 
reduced background fluorescence from the secondary antibody. After incubation with the 
antibodies and Phalloidin, the reactions were mounted on slides, and imaged using a Flowview 
Olympus Confocal microscope under 40x and 60x oil objectives. 
To image the actin bundling ability of Shrm2 SD1, the above reactions were performed 
using Ruby-Shrm2A_D or CD, described above. Actin was detected using Alexa488 Phalloidin 
(1:10 dilution, 1µL per reaction). Slides were prepared and imaged in the same manner as above.  
4.5 EM GRID PREPARATION 
4.5.1 TEM grids 
Actin/Shroom bundles were prepared as above and imaged via negative stained EM grids with 
Transmission Electron Microscopy (TEM) in two ways. The first method was as follows: 400 
mesh Copper grids coated in Formvar and Carbon were glow discharged for 1 min. 10 µL of 
sample was spotted on the grid and incubated for 30 seconds at room temperature. The sample 
was rinsed 6 times with ddH2O for a total of 30 seconds. A solution of 1% Uranyl Acetate was 
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spotted on the grids. The Uranyl Acetate was replaced 2 times, for a total staining time of 30 
seconds. Grids were dried with Whatman filter paper and stored at RT. The second method 
utilized 400 mesh Copper grids with no coating. Mica, sputter coated with Carbon, was trimmed 
into a thin rectangle. This piece of mica was slowly inserted into a convex drop of approximately 
170 µL of actin or actin with Shroom SD1, then ddH2O, and finally 1% Uranyl Acetate negative 
stain. This was done at a fixed 45-degree angle, so the carbon would float on the surface, with 
each step lasting 30 seconds. While the mica was in the negative stain, an uncoated grid was 
touched to the surface of the drop to pick up the floating carbon. This method provided less 
coverage of the grid, but reduced background noise with a more even negative stain of the 
sample. Images where taken on the FEI-Morgagni at the University of Pittsburgh, Department of 
Biology, SRSS Facility. Briefly, negative stained grids were imaged at 80V with magnification 
between 7,100x (.006915 µm/pix) up to 140,000x (.318008 nm/pix). 
4.5.2 Cryo-Grids 
Cryo-Grids were prepared with actin bundling reactions consisting of F-actin and Shrm2A_E. 
The reactions were run as described above but for 10-20 minutes, instead of 30 minutes to reduce 
the size of the actin bundle, prior to being spotted on 400um grids coated with carbon. The 
carbon coating contained evenly spaced holes for the vitreous ice to form, but also allowed the 
actin bundles to stick to a surface and span the holes. The carbon coating was essential because 
tests of grids without the carbon coating did not contain any actin bundles. The sample was 
blotted from one side only for 8 seconds then plunged into liquid ethane and stored in liquid 
nitrogen. This was done on a FEI-Vitrobot in Dr. Conway’s lab at the Department of Structural 
Biology at the University of Pittsburgh School of Medicine. It was critical to blot from only 1 
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side, as large objects can be blotted away from the grids when the standard 2-sided blotting it 
performed. Preliminary images were taken on the FEI-Tecnai F-20 at the Department of 
Structural Biology, University of Pittsburgh School of Medicine. 
4.6 FAST FOURIER TRANSFORM (FFT) AND INVERSE FFT 
Image of actin bundles and filaments were first rotated in NIH ImageJ so that the filaments of the 
bundles ran longitudinally. A selection was made of the bundle where the filaments were 
parallel, and then the FFT function was run on that selection. The resulting power spectrum was 
trimmed based on guidance from Dr. Alexies Huet of the Conway lab to remove artifacts of the 
microscope, visible as a ring in the power spectrum (see Appendix B for detail on FFT). The 
trimmed data was used to generate an inverse FFT. 
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APPENDIX A 
A.1  INVESTIGATION OF ROCK COILED-COIL REGION CONFORMATIONS 
As mentioned in the introduction, Rock, phosphorylates non-muscle Myosin II leading to actin 
contractility [88]. This contraction of the actomyosin network is central to cell morphology in 
several developing structures. Rock is a parallel dimer consisting of N-terminal Kinase domains, 
central coiled-coil regions and C-terminal Plekstrin Homology (PH) and C1 domains [64, 65, 80, 
83, 88]. The Dimerization domain is C-terminal to the Kinase domain [64]. Rock is believed to 
be inhibited through a direct interaction between the Kinase domain and PH/C1 domains (Fig. 
A1.1.) [80]. Within the coiled-coil region are two known binding domains, a Shroom Binding 
Domain (SBD) and RhoA Binding Domain (RBD) [72, 82, 86]. It has been shown that Rock is 
activated through the binding of RhoA GTPase to the RBD [83]. Work from the VanDemark lab 
suggests that binding of Shroom’s SD2 to the SBD also can activate the Kinase. This interaction 
in the coiled-coil region is predicted to displace the PH/C1 domains from the kinase domain. In 
fact, displacement of the C-terminus of Rock, either by proteolysis, binding to lipids, or 
mutation, renders the Kinase constitutively active [72, 80, 83, 105-107]. 
While we understand how Rock can be activated, very little is known about the 
conformational changes that occur for Rock to achieve the inhibited state or active state. Solved 
structures of pieces of the coiled-coil region are all parallel coiled-coil dimers, with little 
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suggestion that they are able to bend [72, 82, 86, 87]. There has been no evidence for a hinge in 
the region. Based on these observations and hypotheses, my early work focused on trying to 
determine the possible conformations that Rock’s coiled-coil region, as well as full-length Rock, 
is capable of adopting. The following describes my efforts to that end, using several different 
techniques. 
 
 
Figure A1.1: Model of Rock activation via binding of Shroom and/or RhoA. 
Rock is inhibited through an interaction between the C-terminal PH/Cys-Rich domains and the Kinase domains. We 
believe this interaction is achieved through an intra-molecular interaction and not an inter-molecular interaction. 
Rock is activated by binding of Shroom or RhoA, possibly through steric hindrance of the closed conformation. 
RhoA	
Shroom	
Rock:	Auto-inhibited/Inac2ve	
Rock:	Open/Ac2ve	
Kinase	
SBD	 RBD	
PH/Cys-Rich	
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A.2 RESULTS AND DISSCUSION 
A.2.1 Purification 
After optimizing expression of the Rock coiled-coil proteins (6xHis-hRock1 436-1094 and GST-
hRock1 593-1062), plasmids were transformed into the RosettaII E. coli expression cells. The 
additional tRNAs expressed by these bacteria increased total expression compared to that of 
BL21 or RIPL cells. Additionally, using freshly transformed cells to start a liquid overnight 
culture for auto-induction increased the total yield and 6 L overnight auto-inductions were 
necessary to yield sufficient protein (750µL of 11mg/mL from 6L). Later, for use with TEM, less 
total protein (final 5mLs of 1mg/mL) was needed and smaller growths were performed (1-2L). 
 After growing cultures for 24 hours at room temperature, the cells were collected by 
centrifugation at 6,000xg for 10 minutes. The cells were flash frozen and stored at -80°C or 
immediately resuspended to a concentration of 10 mg/ml of cells/Lysis buffer. The Lysis buffer 
used for 6xHis-hRock1 436-1094 was: 500mM NaCl, 25mM Tris, 5mM Imidazole, 1mM βME, 
at pH8 plus protease inhibitors Leupeptin, Pepstatin, Aprotinin and PMSF at 1:1000x ratios. The 
addition of these 4 protease inhibitors was necessary to reduce the degradation of the full-length 
protein (data not shown). The cells were lysed by homogenization with the Avestin	Emulsiflex 
and soluble proteins were separated from insoluble cell matter by centrifugation at 12,500xg for 
30 minutes at 4C.  
The supernatant from 6xHis-Rock 436-1094 was passed over a Ni-sepharose gravity 
column. Several wash steps similar to those described in the Materials and Methods for the 
preparation of the Shroom SD1s were used. 6xHis-Rock 436-1094 was eluted from the column 
using Lysis buffer with 200mM Imidazole and fractions were assayed by SDS-PAGE to 
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determine yield and stability. Fractions containing 6xHis-Rock 436-1094 were treated with 
6xHis-TEV protease, purified by the VanDemark Lab, for a minimum of 3 hour at room 
temperature while dialyzing into TEV buffer (500mM NaCl, 25mM Tris, 8% glycerol, pH 8.5). 
The cleaved protein was then run over a Ni-sepharose gravity column to separate the cleaved 
protein from the His tag and His-TEV. Flow through was collected and dialyzed into a 25mM 
Tris, 50mM NaCl, 2% glycerol, pH 8 buffer overnight at 4C. The dialyzed protein was then 
filtered, loaded onto an anion-exchange column, and eluted using an increasing gradient of NaCl 
in 25mM Tris, 2% glycerol at pH8. Typically, the desired protein eluted from the column at 
around 350-450 mM of NaCl. The fractions were analyzed by SDS-PAGE and Coomassie stain. 
Fractions containing the highest concentration of full-length protein were then concentrated to a 
volume around 3mL and loaded onto an S500 size exclusion chromatography column for final 
purification. The sample eluted off as a single peak. Given that Rock is a parallel dimer, it is 
likely that degradation products remain because they are part of a dimer. Final purification of 
Rock436-1094 can be seen in Fig. A1.2 lane 2. 
GST-hRock1 593-1062 was resuspended in NETN (100mM NaCl, 20mM Tris pH8, 
.5mM EDTA, and .5% NP-40) buffer and purified in the same way as His-hRock1 436-1094, 
however the supernatant was passed over a gravity glutathione-sepharose column. Protein was 
eluted with NETN buffer containing 500mM glutathione. Eluted protein was dialyzed into the 
same low salt buffer as hRock1 436-1094 prior to anion-exchange chromatography. The GST-
tag was not cleaved from the protein. Fractions were analyzed by SDS-PAGE and Coomassie 
stain. The fractions covering the center of the peak were collected and concentrated for further 
experiments. This protein was only used for TEM. Final purification of GST-hRock1 593-1062 
can be seen in Fig. A1.2 Lane 1. 
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Figure A1.2: Purified hRock1 CC proteins used for these studies.  
Both of these pieces of the Coiled-coil region of Rock degraded even in the presence of protease inhibitors during 
purification.  
A.2.2 Crystallography 
Once I had sufficiently pure protein samples of hRock1 436-1094, I proceeded with 
crystallization trials. I attempted to crystalize the protein in the 12 most common conditions used 
for solved PDB structures, as compiled by the VanDemark Lab. However, the proteins 
precipitated out of solution within 24 hours in most of the conditions tested. By 2 weeks there 
were still no crystals or promising hits from this range of crystallization buffers. In addition, I 
also tried two large commercial screens, Wizard II (Rigaku, SKU:1009531) and JCSG+ 
(Molecular Dimensions, MD1-37) . There were 3 potentially promising hits that were further 
examined by varying the ratios of precipitant, salt, and protein. However, none of these trials 
yielded suitable crystals. The conditions either precipitated the protein, yielded salt crystals, or 
remained clear even after 4 months. At this point, we abandoned crystallization as an option for 
understanding the structure of the entire coiled-coil region. Given our hypothesis that the coiled-
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coil region is reasonably flexible, it is understandable that it might not form ordered crystals. For 
this reason, we explored alternate techniques for understanding the possible conformations of the 
Rock coiled-coil region. 
A.2.3 Static Light Scattering 
One way to determine if the coiled-coil region of Rock is indeed flexible would be to measure 
the average length of this region in solution. Therefore, I utilized the technique of Static Light 
Scattering (SLS) to accomplish this. This technique measures the angle of refraction of a laser 
directed at a sample in solution [108, 109]. This measurement can be translated into a Radius of 
gyration, which is approximately equal to the radius of the sphere created by a tumbling 
molecule in solution. This allows us to relate the Radius of gyration directly to the overall size of 
the molecule. If the coiled-coil region is mostly a long rod, rotating in all directions, I expect to 
observe a sphere in which the diameter is equal to the overall length of the molecule. Conversely, 
if the coiled-coil region can fold onto itself or is flexible, I would expect an average radius of 
gyration that is smaller then the predicted length of the linear coiled-coil.  
 When hRock1 463-1094 was subjected to this analysis at two concentrations (1mg/ml 
and 0.5mg/ml) I observed a range of radii that fit under a bell curve (Fig. A1.3). The bell curves 
of the replicates have similar minimums, maximums and peaks. The average minimum radius 
was approximately 10 nm and the maximum average was approximately 33 nm. Given the 
correlation to size of the molecule, hRock1 436-1094 is capable of achieving a conformation 
around 20 nm to 66 nm in length. This fits well with the maximum predicted size of this piece of 
the coiled-coil region of ~70nm. The measurements of SLS often under represent the actual size, 
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due to weak signal from the edges of a molecule [109]. The range of sizes measured as the 
coiled-coil region suggests it is a dynamic, flexible molecule, and not strictly linear or folded. 
 
Figure A1.3: Static light Scattering of hRock1 436-1094.  
Percent Mass of hRock1 coiled-coil 436-1094 at a given radius of gyration. At two different concentrations of 
Rock’s coiled-coil representing the same range of possible diameters. 
A.2.4 Small Angle X-Ray Scattering 
Another technique that can be used to determine the shape of a molecule is Small Angle X-Ray 
Scattering (SAXS). SAXS utilizes similar principles as crystallography, in that diffraction data 
from x-rays is used to determine the location of atoms in a molecule [110-112]. However for 
SAXS a liquid solution is used, eliminating the need to crystalize. This seemed a possible 
alternative for the Rock coiled-coil region because we were having difficulty crystalizing the 
protein.  
The SAXS machine at the Department of Structural Biology did not yield any usable data 
for a reconstruction due to the fact that the machine in question has a particularly weak X-Ray 
source. Due to the weak source it was difficult to get scattering data of any kind. I tried several 
times running samples of buffer alone as well as my sample of hRock1 436-1094 for either 7-
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hour or 14-hour runs. Neither of these produced data that was trustworthy due to the lack of 
signal strength. Given these complications we proceeded with other techniques to visualize 
molecules of Rock. 
A.2.5 Transmission Electron Microscopy 
In my continued attempts to understand the conformation of the Rock coiled-coil region, I 
pursued Transmission Electron Microscopy (TEM). Grids were prepared in the same manner as 
described in the Materials and Methods for TEM grids of F-actin + Shroom SD1. Initially, I 
made grids using hRock1 436-1094. While I observed structures that could possibly be 
molecules of Rock, given their small size and the background signal it was impossible to make 
any conclusions from these grids (Fig. A1.4 A). I then made grids using the GST-hRock1 593-
1062 in the hopes that the globular tag of GST would aid in visualization. The grids were also 
made with F-actin present to act as a staining control. While F-actin could be visualized, there 
were no molecules that were conclusively GST-hRock1 593-1062. The problem remained that it 
was difficult to tell the difference between background and molecules that were smaller than F-
actin. Finally, I made grids of full-length hRock1 purified from MDCK cells by Jenna Zalewski. 
While there may have been some promising leads on the grids (Fig. A1.4 B), no conclusive data 
resulted. In summary, this procedure did not yield enough contrast to clearly visualize Rock. 
A group recently published a composite structure for full-length Rock that they generated 
with TEM [81]. Rock is easily visualized in their images. The difference between my TEM 
attempts and theirs lies in the technique used in making the grids. Whereas I used a standard 
negative staining technique in which Uranyl Acetate is spotted on top of the sample, leading to 
reduced contrast, they utilized a low-angle shadowing technique [113]. This technique applies 
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carbon at a specific angle to the sample grid prior to negative staining. This increases the 
contrast, and is particularly useful in visualizing small molecules. If this work is pursued in the 
future, I believe attempting this technique will greatly increase our chances of visualizing single 
molecules of Rock. 
Based on the sample image provided in their article, it appears that full-length Rock’s 
coiled-coil region is not a straight rod, but that the coiled-coil region is flexible. While some 
molecules are fully extended, others were bent enough to bring the Kinase domains in close 
proximity to the PH/C1 domains. The range of conformations visible in the single image actually 
supports the idea that the coiled-coil region is flexible and allows dynamic interaction between 
the kinase domain and the C-terminus even though the authors say Rock is a ridged molecule.  
 
Figure A1.4: Inconclusive TEM of hRock1 Coiled-Coil and Full-Length protein. 
A) hRock1 coiled-coil TEM, false colored to highlight what is potentially Rock B) hRock1 Full-Length, false 
colored.. Due to its small size, TEM, with conventional negative staining techniques, was inconclusive for both the 
coiled-coil region as well as full-length hRock1. 
 
 
A
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APPENDIX B 
B.1 FOUIER TRANSFORM AND USE WHEN ANALYZING TEM 
Fourier Transform (FT) allows for the conversion of an image into spatial data and helps to 
define a relationship between a projection (the image) and the original molecule. It is, in essence, 
a mathematical representation of the image. The output of a FT, similar to that of a diffraction 
pattern generated in x-ray crystallography, gives you information on the spacing of elements of 
an object. FT of EM images has been a method of data analysis since the 1960s [114]. If there is 
repetition in the distance between points, such as the cross over point in an actin filament that is 
360Å apart, these compound to create an increased signal and form the power spectrum, which is 
the output of an FT of an image. Where these signals fall in the power spectrum are layer lines. 
Equation B1, derived by Sukow and DeRosier [94], explains that the FT of an actin raft, which is 
a flat actin bundle, is the summation of the FT of a single actin filament.  
 
Equation B1: Fourier Transform of an Actin Raft             
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This filament is defined as centered at the location xk and zk, with rotation ϕk . “Gn is the radial 
dependence of the nth order component of the lth layer line. Zl is the axial position of the lth 
layer line and k is an integer which denotes the index of the filament and the raft” [115].   
With the theory of utilizing FT to analyze actin and actin bundles/rafts established, image 
processing software, ImageJ ((NIH, Bethesda, MD, USA) contains a function that will perform a 
discrete Fourier Transform of images, known as a Fast Fourier Transform (FFT) as well as the 
inverse (inverse FFT) that allows a simple FT to be done on a selection of an image defined by 
the user. FFT is done to determine if multiple images can be compiled to build a reconstruction. 
Images can only be compiled if their FFT are similar, which would mean that the helical pitch 
and spacing of filaments are the same. Determining that the actin filaments are in the same 
orientation and that the spacing of the turns of the helix are the same are critical to an eventual 
reconstruction. While performing TEM, there are often artifacts from the microscope that affect 
the signal and background. Data trimming can help to remove these artifacts, however, you can 
lose some information in doing so. For example, the TEM often produces a signal that can be 
seen in the power spectrum of the FFT as a ring. FFT can be trimmed to remove these data points 
and those from resolutions not truly achievable by TEM (better than 6Å). If the power spectrums 
from multiple filaments or bundles are the same, the images can be used to begin to compile a 
3D reconstruction [94, 98, 116, 117]. 
 The power spectrum can also be reinterpreted into an image, an inverse FFT. If your 
molecule has genuine structural repeats, they will appear in the inverse FFT as well. If your 
inverse FFT is similar to that of the original image it leads credence to the information you are 
compiling on your structure. Measurements of spacing of the repeats, or filament spacing can be 
made from these inverse images.  
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